Dr. Gregory Dongkyu Lee , MD
Ophthalmology • Cumming, GA
990 Sanders Rd Ste 100
Cumming, GA 300415960
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on June 23, 2011; this date does not establish years in practice.
-
Published CMS data list 74,139 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J2777 — Injection, faricimab-svoa, 0.1 mg: 63,000 service units.
- 92134 — Imaging of retina: 2,894 service units.
- J2782 — Injection, avacincaptad pegol, 0.1 mg: 2,140 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 21 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 683 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Prednisolone Acetate — 233 prescription fills, including refills.
- Moxifloxacin (Moxifloxacin Hcl) — 161 prescription fills, including refills.
- Dorzolamide-Timolol (Dorzolamide Hcl/Timolol Maleat) — 123 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 8 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 95% of clinicians listed under Ophthalmology in Georgia (2024, 343 clinicians with data). Median for this group: 1,908. Middle half: 961 to 3,364.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 6,938 in 2020 to 74,139 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
990 Sanders Rd Ste 100
Cumming, GA 300415960
NPPES lists 1 additional practice-address record in New York, NY. See the list
Source: CMS NPPES NPI Registry, practice location records; release date unavailable.
CMS Doctors and Clinicians lists 1 group name: Georgia Retina, Pc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
Rutgers R W Johnson Medical School (Cam/new Bruns/pisc)
2011
What Public CMS Data Show
Ophthalmology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
1,206 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $4,160,857 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $3,269,097 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
1,139 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$21,687 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $127,282.45 across 142 records.
By nature of payment (3 largest of 5)
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program: $89,466.72 across 20 records.
- Compensation for serving as faculty or as a speaker for a medical education program: $14,718.00 across 4 records.
- Travel and Lodging: $13,043.08 across 66 records.
Reporting-company totals (3 largest of 9)
- Genentech, Inc.: $59,077.69 across 74 records.
- Regeneron Pharmaceuticals, Inc.: $30,015.01 across 28 records.
- Astellas Pharma US Inc: $20,231.21 across 16 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
15 years (graduated 2011)
CMS Doctors and Clinicians data list 2011 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2011
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Lee has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Lee as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Cumming and Georgia
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 95% of clinicians listed under Ophthalmology in Georgia (2024, 343 clinicians with data). Median for this group: 1,908. Middle half: 961 to 3,364.
Too few clinicians listed under Ophthalmology in Cumming have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A higher Medicare-allowed amount than 95% of clinicians listed under Ophthalmology in Georgia (2024, 343 clinicians with data). Median for this group: $237,983. Middle half: $101,835 to $393,154.
Too few clinicians listed under Ophthalmology in Cumming have Medicare Part B data for 2024 to compare.
Paid by Medicare
A higher Medicare payment amount than 95% of clinicians listed under Ophthalmology in Georgia (2024, 343 clinicians with data). Median for this group: $175,062. Middle half: $73,444 to $278,631.
Too few clinicians listed under Ophthalmology in Cumming have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
Fewer Part D prescriptions than 65% of clinicians listed under Ophthalmology in Georgia (2024, 377 clinicians with data). Median for this group: 1,247. Middle half: 412 to 2,315.
Too few clinicians listed under Ophthalmology in Cumming have Medicare Part D data for 2024 to compare.
Part D drug cost
A lower Part D drug cost than 70% of clinicians listed under Ophthalmology in Georgia (2024, 377 clinicians with data). Median for this group: $119,597. Middle half: $20,280 to $291,575.
Too few clinicians listed under Ophthalmology in Cumming have Medicare Part D data for 2024 to compare.
7 active clinicians are listed under Ophthalmology with a practice address in Cumming, GA (538 in Georgia).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 969% from 6,938 in 2020 to 74,139 in 2024.
- 2020: 6,938
- 2021: 10,400
- 2022: 17,071
- 2023: 48,606
- 2024: 74,139
-
Medicare-allowed amount
Medicare-allowed amount increased 123% from $1,868,494 in 2020 to $4,160,857 in 2024.
- 2020: $1,868,494
- 2021: $2,703,034
- 2022: $3,482,783
- 2023: $3,660,766
- 2024: $4,160,857
-
Paid by Medicare
Paid by Medicare increased 121% from $1,476,738 in 2020 to $3,269,097 in 2024.
- 2020: $1,476,738
- 2021: $2,129,426
- 2022: $2,736,058
- 2023: $2,876,633
- 2024: $3,269,097
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 136% from 290 in 2020 to 683 in 2024.
- 2020: 290
- 2021: 503
- 2022: 484
- 2023: 577
- 2024: 683
-
30-day fills
30-day fills increased 206% from 373 in 2020 to 1,139 in 2024.
- 2020: 373
- 2021: 702
- 2022: 798
- 2023: 1,008
- 2024: 1,139
-
Part D drug cost
Part D drug cost increased 104% from $10,627 in 2020 to $21,687 in 2024.
- 2020: $10,627
- 2021: $22,046
- 2022: $21,075
- 2023: $22,471
- 2024: $21,687
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 4736% from $2,631.99 in 2021 to $127,282.45 in 2025.
- 2021: $2,631.99
- 2022: $4,424.16
- 2023: $19,722.19
- 2024: $49,169.19
- 2025: $127,282.45
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 142 records totaling $127,282.45.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Apellis Pharmaceuticals, Inc. |
Compensation for serving as faculty or as a speaker for a medical education program
Cash or cash equivalent
|
Syfovre | General | $6,426.00 |
| Astellas Pharma US Inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Izervay | General | $6,000.00 |
| Astellas Pharma US Inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Izervay | General | $6,000.00 |
| Genentech, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Susvimo | General | $5,840.00 |
| Genentech, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Susvimo | General | $5,840.00 |
| Genentech, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Susvimo | General | $5,840.00 |
| Genentech, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Susvimo | General | $5,840.00 |
| Genentech, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Susvimo | General | $5,840.00 |
| Genentech, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Susvimo | General | $5,840.00 |
| Genentech, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Susvimo | General | $5,840.00 |
| Regeneron Pharmaceuticals, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
EYLEA HD | General | $5,792.00 |
| Regeneron Pharmaceuticals, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
EYLEA HD | General | $5,792.00 |
| Regeneron Pharmaceuticals, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
EYLEA HD | General | $5,792.00 |
| Apellis Pharmaceuticals, Inc. |
Compensation for serving as faculty or as a speaker for a medical education program
Cash or cash equivalent
|
Syfovre | General | $5,292.00 |
| Astellas Pharma US Inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Izervay | General | $5,000.00 |
| Genentech, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Susvimo | General | $3,650.00 |
| Regeneron Pharmaceuticals, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
EYLEA HD | General | $3,258.00 |
| Genentech, Inc. |
Consulting Fee
Cash or cash equivalent
|
Susvimo | General | $2,860.00 |
| Regeneron Pharmaceuticals, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
EYLEA HD | General | $2,382.38 |
| Genentech, Inc. |
Consulting Fee
Cash or cash equivalent
|
Susvimo | General | $2,370.00 |
| Regeneron Pharmaceuticals, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
EYLEA HD | General | $1,613.67 |
| Apellis Pharmaceuticals, Inc. |
Compensation for serving as faculty or as a speaker for a medical education program
Cash or cash equivalent
|
Syfovre | General | $1,500.00 |
| Apellis Pharmaceuticals, Inc. |
Compensation for serving as faculty or as a speaker for a medical education program
Cash or cash equivalent
|
Syfovre | General | $1,500.00 |
| Ocular Therapeutix, Inc. |
Consulting Fee
Cash or cash equivalent
|
— | General | $1,500.00 |
| Regeneron Pharmaceuticals, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
EYLEA HD | General | $1,206.67 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J2777
Injection, faricimab-svoa, 0.1 mg
|
63,000 | 213 | $107.31 | $34.48 |
|
92134
Imaging of retina
|
2,894 | 1,166 | $129.00 | $38.87 |
|
J2782
Injection, avacincaptad pegol, 0.1 mg
|
2,140 | 29 | $168.00 | $108.55 |
|
67028
Injection of drug into eye
|
1,722 | 417 | $1451.80 | $118.42 |
|
92014
Established patient complete exam of visual system
|
1,322 | 909 | $255.00 | $120.94 |
|
J0178
Injection, aflibercept, 1 mg
|
942 | 112 | $2100.00 | $829.46 |
|
J0177
Injection, aflibercept hd, 1 mg
|
664 | 26 | $547.00 | $330.96 |
|
J2778
Injection, ranibizumab, 0.1 mg
|
540 | 31 | $1082.00 | $163.71 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
264 | 264 | $400.00 | $163.64 |
|
92012
Established patient problem focused exam of visual system
|
224 | 183 | $175.00 | $85.66 |
|
J7312
Injection, dexamethasone, intravitreal implant, 0.1 mg
|
133 | 11 | $372.00 | $202.36 |
|
J9035
Injection, bevacizumab, 10 mg
|
87 | 28 | $300.00 | $69.53 |
|
76512
2d ultrasound scan of eye tissue and structures
|
44 | 39 | $361.00 | $43.90 |
|
67145
Photocoagulation treatment to prevent detachment of retina
|
36 | 33 | $1993.89 | $233.43 |
|
92250
Photography of the retina
|
23 | 22 | $200.00 | $34.60 |
|
J3490
Unclassified drugs
|
23 | 13 | $3350.00 | $2128.66 |
|
67036
Removal of eye fluid (vitreous) between lens and retina
|
20 | 20 | $5168.00 | $762.15 |
|
92201
Extended exam of the back part of the eye with retinal drawing
|
17 | 17 | $111.00 | $23.79 |
|
92004
New patient complete exam of visual system
|
16 | 16 | $285.00 | $141.66 |
|
99205
New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
|
16 | 16 | $525.00 | $219.00 |
|
67041
Removal of membrane of retina
|
12 | 12 | $5058.00 | $1137.99 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Prednisolone Acetate | Prednisolone Acetate | 233 | 10,628 | $11,382.17 | 157 |
| Moxifloxacin | Moxifloxacin Hcl | 161 | 2,440 | $2,924.52 | 127 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 123 | 9,320 | $2,038.71 | 53 |
| Latanoprost | Latanoprost | 50 | 2,975 | $354.42 | 17 |
| Brimonidine Tartrate | Brimonidine Tartrate | 34 | 2,038 | $1,402.52 | 16 |
| Timolol Maleate | Timolol Maleate | 33 | 2,176 | $239.48 | 18 |
| Bromfenac Sodium | Bromfenac Sodium | 31 | 696 | $3,159.86 | — |
| Dorzolamide Hcl | Dorzolamide Hcl | 18 | 880 | $185.37 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2024-04-29NUCC Taxonomy Code: 207W00000X
An ophthalmologist has the knowledge and professional skills needed to provide comprehensive eye and vision care. Ophthalmologists are medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, an ophthalmologist prescribes vision services, including glasses and contact lenses.
NUCC Taxonomy Code: 207WX0107X
An ophthalmologist who specializes in the diagnosis and treatment of vitreoretinal diseases.
NUCC Taxonomy Code: 207WX0107X
An ophthalmologist who specializes in the diagnosis and treatment of vitreoretinal diseases.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - OPHTHALMOLOGY
I20190723002466
GA
2264752468
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Georgia Retina, Pc
1100 Johnson Fy Rd Ne, Sandy Springs, GA 303421733
Phone: 4042559096
Secondary Practice Locations
240 E 38th St Fl 13
New York, NY 100162708
Phone: 2122632573
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Ophthalmology (license number reported to NPPES: NY 289000)
Registered at 990 SANDERS RD STE 100, CUMMING, GA 300415960 (Tel: 6786794830)
Registered at 1100 JOHNSON FERRY RD STE 593, ATLANTA, GA 303421733 (Tel: 4042559096)
Ophthalmology (license number reported to NPPES: GA 82692)
NPI status registered as active in NPPES database
Registered at 240 E 38TH ST FL 13, NEW YORK, NY 100162708 (Tel: (212) 263-2573)
Registered at 240 E 38TH ST FL 13, NEW YORK, NY 100162708 (Tel: (212) 263-2573)
Recorded as GREGORY LEE, M.D.
Ophthalmology (license number reported to NPPES: NY 289000)
NPI status registered as active in NPPES database
Registered at 120 N EAGLE CREEK DR, SUITE 500, LEXINGTON, KY 405091827 (Tel: 8592633900)
Registered at 120 N EAGLE CREEK DR, SUITE 500, LEXINGTON, KY 405091827 (Tel: 8592633900)
Recorded as GREGORY LEE, M.D.
Ophthalmology (license number reported to NPPES: KY 48280)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Ophthalmology Specialists in Cumming
- Dr. Byron Cook, MD
- Dr. Matthew Kaufman, MD
- Dr. Samir Vira, MD
- Dr. Bhairavi Dholakia, MD
- Dr. Niraj Desai, MD
- Dr. Milan Patel, MD
Mailing Address
1100 Johnson Ferry Rd Ste 593
Atlanta, GA 303421733
Phone: 4042559096